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Bradycardia-dependent TdP is more prevalent in women (ϳ75%) than men (54, 57) , which parallels the well-established finding for drug-induced LQT type 2 (LQT2). On the other hand, most episodes of TdP in humans are not preceded by profound bradycardia, and more than one factor is often identified (29, 32 (21) and the late Na ϩ current (I Na,L ) (24) . Mathematical simulations of slow HR (SHR) indicated that the long diastolic intervals result in a complete deactivation of the slow component of the delayed rectifying K ϩ current (I Ks ) and complete recovery from inactivation of I Ca,L , which could theoretically explain APD adaptation in bradycardia (5, 27, 61). Besides ion channel kinetics, changes in ionic concentrations in the cytoplasm (intracellular Na ϩ and Ca i ) or extracellular K ϩ may contribute to APD adaptation (13, 22) .
HR and arrhythmias. HRs outside the physiological range may promote arrhythmias through changes in Ca 2ϩ handling (45) . Transitions from slow to fast HR have been extensively studied and shown to create Ca 2ϩ alternans that lead to APD and T-wave alternans, increased dispersion of repolarization (DOR), and arrhythmias (42) . In the setting of ischemia (43, 44) and heart failure (64), arrhythmogenic Ca 2ϩ and APD alternans occur at physiological HR. In drug-induced LQT2, SHR promotes sarcoplasmic reticulum (SR) Ca 2ϩ overload, resulting in spontaneous SR Ca 2ϩ release during the AP plateau and early afterdepolarizations (EADs) (18, 38) . In intact hearts, bradycardia prolongs APD and enhances DOR (16, 60) , which are thought to contribute to LQT2-related arrhythmias.
This project investigates APD adaptation and Ca 2ϩ handling changes during bradycardia in Langendorff-perfused rabbit hearts at low and high magnifications. We show that bradycardia promotes a secondary intracellular Ca 2ϩ (Ca i ) release at the base of the ventricles, which contributes to further APD prolongation, increased DOR, and triggered activity.
METHODS
Heart preparations. New Zealand White rabbits (females, 60 to 120 days old) were euthanized with pentobarbital sodium (75 mg/kg intravenously) and anticoagulated with heparin (200 U/kg intravenously). The heart was rapidly dissected and perfused with Tyrode solution containing (in mM) 130 NaCl, 24 NaHCO 3, 1.0 MgCl2, 4 KCl, 1.2 NaH2PO4, 50 dextrose, and 1.25 CaCl2 (at pH 7.2-7.4), gassed with 95% O2 plus 5% CO2. Temperature and perfusion pressure were continuously monitored and regulated by a feedback systems at 37 Ϯ 2°C and ϳ80 mmHg, respectively. To minimize motion artifact, blebbistatin (5-10 M; Sigma, St Louis, MO) was added to the perfusate for 5-10 min. The heart was immobilized in a chamber and stained with a voltage-sensitive dye (PGH1: 200 l of 1 mg/ml dimethyl sulfoxide) and loaded with a Ca 2ϩ indicator (Rhod-2 AM, 200 l of 1 mg/ml dimethyl sulfoxide). Epicardial bipolar pseudo-EKG was continuously monitored, and the atrioventricular (AV) node was ablated to control HR. Hearts were paced with an epicardial unipolar electrode placed on the lateral wall of the right ventricle, approximately halfway between the apex and base. In pilot experiments, different pacing sites at the apex, base, and posterior were tested and found not to alter the effect of bradycardia on Ca 2ϩ dynamics. For a physiological rate, hearts were paced at a baseline cycle length of 0.5 s [baseline HR (BHR) of 120 beats/min] and for bradycardia at a SHR with a cycle length of 1.2 s (50 beats/min; a profound bradycardia for rabbit hearts). This investigation conformed to the current Guide for Care and Use of Laboratory Animals, published by the National Institutes of Health, and was approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh.
Optical apparatus. An optical apparatus consisting of two CMOS cameras (SciMedia, Ultima One, 100 ϫ 100 pixels) has been used for simultaneous measurement of intracellular Ca 2ϩ transients (CaTs) and membrane potential (V m) changes, as previously described (47) . For long uninterrupted recordings at low magnification, a slow scan rate of 250 frames/s was intentionally chosen to record Ca i and Vm during two to three sets of transitions from BHR to SHR and SHR to BHR. Brief (4 s) recordings were taken at 2,000 frames/s to verify the kinetics of Ca i and Vm upstrokes. Subcellular Vm and Cai signals were measured at high magnification at scan rates of 200 frames/s to achieve a high signal-to-noise ratio without compromising the kinetics of the signals. The anterior surface of the heart was illuminated with a 520 Ϯ 30-nm excitation beam, and the fluorescence emitted by Rhod-2 and PGH1 was separated by a dichroic mirror (660 nm) and was focused on two CMOS cameras, as previously described (47) . surface of the heart using a Nikon camera lens (50 mm, 1:1.2). For subcellular imaging, the heart was perfused horizontally in a chamber on the stage of an upright microscope (Olympus BX61W1) using a ϫ40 water immersion objective (Olympus, ϫ40/LUMPLFL). Fluorescence microscopy to image intact hearts at the subcellular level offers important advantages compared with previous confocal imaging studies (2, 50) . The lack of confocal apertures results in considerably greater light throughput (2 to 3 orders in magnitude), making it possible to measure Ca i and Vm signals from two-dimensional fields of view (instead of line scans) with a greater signal-to-noise ratio (Ͼ80/1) and temporal resolution (up to 2,000 frames/s). Butterworth low-pass temporal filtering (60-to 100-Hz cutoff) was used if needed, but spatial filtering was not applied to maximize spatial resolution. The limitation of bright field over confocal microscopy is the blurring caused by background scattered light from deeper layers of muscle and the lower voxel resolution. In the present configuration, the ϫ40 objective has a depth of field of ϳ 0.5 m and an x-y resolution of 1.5 ϫ 1.5 m 2 . The confocal apertures would block scattered light emanating from out-of-focus fluorescence sources and would improve contrast by reducing blurring. More relevant to this study, nonconfocal optics does not significantly alter Ca i kinetics in maps of subcellular Ca 2ϩ waves in three dimensions. A recent analysis of spark properties recorded with confocal imaging revealed that the spatial widths and rise times of sparks were similar when recorded in-focus compared with out-of-focus by Ϯ1 m (51). We estimated that imaging with a ϫ40 objective represented the summation of Ca i or (Vm) signals over a voxel (1.5 ϫ 1.5 ϫ 3.0 m 3 ) with reduced spatial but an improved temporal resolution compared with confocal microscopy.
Study protocol. The AV node was ablated by cauterization to allow control of HR by pacing. Hearts were paced at a cycle length of 0.5 s, which was taken as a BHR, and the cycle length was then lengthened to 1.2 s to impose a bradycardia or a SHR. APs and CaTs were continuously recorded during several (typically 3) transitions from fast to slow and back from slow to fast HR. Changes in HR led to gradual changes in APD until a new steady state was attained. The time course of APD adaptation required continuous recordings of 3-5 min to reach a steady state of APDs during transitions from BHR to SHR (bradycardia) and 5-10 min in going from SHR to BHR.
Pilot experiments were carried out to select the BHR and the SHR that were used in this study. A SHR of 50 beats/min was chosen because it could be maintained reliably without interruptions by an occasional extra beat yet was effective to expose spatial heterogeneities of CaT caused by secondary Ca 2ϩ release (SCR). Similar, but less pronounced, effects were observed at 0.9-and 1.0-s cycle lengths. A basic HR of 120 beats/min was chosen because 1) this HR was well tolerated and did not result in rundown of the preparations, 2) capture with pacing electrodes was reliable during uninterrupted recordings, and 3) spatial heterogeneities of AP and CaT were negligible compared with still faster rates. Data analysis. Activation time at each site was calculated from maximum first derivative of the fluorescent signal [(dF/dt) max] of the local AP or CaT upstroke. APD and CaT duration (CaTD) at each site were calculated from the interval between (dF/dt)max and the recovery of Vm and CaT traces to 20% of baseline (APD80 or CaTD80), respectively. Automatic measurement of APD80 and CaTD80 from all pixels (100 ϫ 100 pixels) was used to calculate mean APD80 and CaTD80. The dispersion of APD80 was calculated from the SD of APD80. The time constant () of mean APD (from all 100 ϫ 100 pixels) adaptation to HR changes was calculated by fitting the transitions from BHR to SHR (f¡s) and from SHR to BHR (s¡f) with monoexponential functions. Rate and time-dependent mean APD80 and regional variation in 100 ϫ 100 pixels were statistically evaluated. Bradycardia-dependent APD and CaT prolongation and dispersions before and after 3-(4-benzylcyclohexyl)-1-(7-methoxy-2,3-dihydrobenzo[f] [1, 4] thiazepin-4(5H)-yl)propan-1-one (K201; 1 M) perfusion were compared. K201 was synthesized according to a previously reported procedure (63) . The amplitudes of SCR (ASCRs) were assessed by calculating areas under curves of normalized CaT from the inflexion time points of Ca i downstrokes to the time points of CaTD80 at each pixel. All 10,000 recordings (100 ϫ 100 pixels) were used to generate the scatterplots to correlate spatial heterogeneities of ASCRs to the dispersion of APD80. Regional differences of APD80, base of right ventricle (RVB), and apex of left ventricle (LVA) were compared for statistical significance using two-tailed t-test. Box-whisker diagrams are used to visualize the distribution of the data. The top and bottom whiskers define, respectively, the maximum and minimum values; the top and bottom of the box define the 75th and 25th percentiles, respectively, and the line within the box is the median in the data set.
Western blot analysis. Female New Zealand White rabbits (3 mo old) were euthanized as described above, the hearts were perfused with Tyrode solution, and ventricular tissue samples (ϳ50 mg) were dissected from the base (B) and apex (A) of the epicardium. Proteins were isolated as previously described (17), were separated by SDS-PAGE (50 g/sample), and transferred to polyvinylidene difluoride membranes, which were probed by standard techniques. SD was used as a measure of dispersion and was calculated from 10,000 recordings (100 ϫ 100 pixels) at BHR baseline and after 5 min of SHR. G: mean APD80 measured at BHR from RVB (24 pixels) and LVA (24 pixels) was not significantly different (left), but after 5 min of SHR, mean APD80 was significantly longer at RVB than LVA (middle) and as a percent change in APD80 (right). AU, arbitrary unit, dF/F, fractional fluorescence change.
ized with respect to ␤-actin. Differences between the base and apex were analyzed with two-tailed t-test and considered significant at P Ͻ 0.05. Antibodies against rabbit Cav1.2␣, sarcoplasmic reticulum Ca 2ϩ -ATPase 2 (SERCA2), ERG and ␤-actin were obtained from Santa Cruz Biotech (Cat. No. SC-103588, SC53010, 15968, and 81178, respectively), NCX1 and ryanodine receptors (RyR2) were obtained from Thermo Scientific (Cat. No. MA3-926 and MA3-916, respectively), and Nav1.5 was obtained from Alomone (Cat. No. ASC-005).
RESULTS

Bradycardia-induced changes in CaT.
Low-resolution imaging of V m and Ca i signals during HR transition was performed to confirm the reproducibility of rate-dependent changes. APD 80 adaptation was reproducible from heart to heart and during repeated cycles (3 to 4 per heart) of transitions from 120 (BHR) to 50 (SHR) beats/min and back. Figure 1A illustrates a continuous sequence of two complete cycles of APD adaptation from BHR to SHR. From a HR of 120 beats/min (not shown), a transition to SHR resulted in a gradual prolongation of APD 80 and QT interval which was fully reversed by pacing at a BHR. The mean ⌬APD 80 in the first episode of SHR increased by 55.2 Ϯ 10.9%, which was similar to that measured in a second episode of SHR (51.25 Ϯ 8.2%) (P Ͻ 0.05, n ϭ 4). Fig. 1 , B and C, illustrates optical APs and EKG recordings measured at time points a-e (Fig.  1A ). An AP recorded at the onset SHR (trace a) is markedly shorter than at steady-state SHR (trace b). APs measured at the next BHR are shorter than at steady-state SHR. Similarly, T-wave amplitudes were markedly larger at SHR than at BHR or the initiation of SHR (Fig. 1C) . The changes in T-wave amplitude relative to the QRS amplitude are a measure of changed repolarization gradient and the ratio of T wave to QRS amplitude was statistically greater at steady-state SHR than BHR (Fig. 1C, right , P Ͻ 0.01, n ϭ 15 trials from 5 hearts).
At BHR, the time course of AP and CaT signals exhibited the expected rapid rise and monophasic recovery to baseline. After the transition to SHR, diastolic levels of Ca i decreased gradually and APD 80 and CaTD 80 exhibited the expected time-dependent prolongation ( Fig. 2A) . Most interesting was the gradual prolongation of CaTD 80 , which was associated with a slowing down of the CaT downstroke, the appearance of a Ca i plateau, and a small secondary Ca 2ϩ peak. This increasingly more pronounced SCR during the AP plateau was associated with APD prolongation, changes in the shape of APs, ) at the center of the line a-a=. Note that SHR leads to low-amplitude Cai instabilities and subcellular waves during diastole that are not seen at low magnification and disappear at BHR. Subcellular diastolic Cai waves were not synchronized among the neighboring cells. They were averaged out at low magnification. A supplementary movie file is provided to visualize the spatial and temporal heterogeneities of systolic and diastolic Cai (supplementary movie 1). E: statistical comparison of the number of secondary Ca 2ϩ elevations (SCaiE; includes both systolic and diastolic elevations) between BHR, SHR, and return back to BHR. The data are derived from all the pixels in the field of view. **P Ͻ 0.001. with a tight linear correlation between CaTD 80 and APD 80 ( Fig. 2A) . Reversal to BHR suppressed SCR gradually, altered the shape of AP repolarization, and shortened APD 80 and CaTD 80 (Fig. 2B) . APD 80 adaptation curves exhibited monoexponential time courses with significantly different time constants in going from BHR to SHR ( f¡s ϭ 48 Ϯ 9.2 s) compared with from SHR to BHR ( s¡f ϭ 30.4 Ϯ 4.7 s; P Ͻ 0.05, n ϭ 5 hearts). A similar trend was reported for QT adaptation in patients upon sudden HR changes (49) .
Regional heterogeneity of SCR. We calculated the spatial correlation between changes in AP and CaT to evaluate the interplay between V m and Ca i . The distribution of SCR was heterogeneous, being more pronounced at the RVB than the LVA. The superposition of CaT measured at BHR and 5 min of SHR exemplify the heterogeneous changes that occur from RVB to LVA (a, b, and c) on the epicardium (Fig. 3, A and B) . The delay between the first and second release of Ca 2ϩ (SCR) was measured from the time interval between (dF/dt) max and the inflection point (d 2 F/dt 2 ϭ 0) of the CaT downstroke. When measured for all 10,000 pixels in 5 hearts, SCR occurred 184.4 Ϯ 9.7 ms after the first Ca 2ϩ release, demonstrating a highly reproducible change in Ca 2ϩ dynamics at all sites on the base of the epicardium and from heart to heart. Similarly, the ASCR was assessed by measuring the area under the CaT curve between the inflection point (d 2 F/dt 2 ϭ 0) and CaTD 80 .
The interplay between SCR and V m was evaluated by correlating ASCR with APD 80 . Maps of APD 80 and ASCRs are shown for BHR and after 5 min of SHR, which increased the dispersion of APD 80 and ASCRs (P Ͻ 0.01, n ϭ 7 hearts) (Fig. 3, C and D) . Most interesting was the statistical analysis that revealed an enhanced correlation between ASCRs and APD 80 (r ϭ 0.90 Ϯ 0.03) during SHR compared with BHR (r ϭ 0.66 Ϯ 0.18) (P Ͻ 0.01, n ϭ 7 hearts) (Fig. 3E) . SHR significantly increased the dispersion of APD 80 compared with BHR (P Ͻ 0.01, n ϭ 7; Fig.  3F ), and mean APD 80 (averaged over 24 pixels) was significantly longer at the RVB than the LVA (P Ͻ 0.05, n ϭ 7, Fig. 3G) .
Subcellular imaging. Hearts were mapped at high magnification to elucidate the cellular mechanisms underlying heterogeneities of SCR; this visualized CaT changes in unprecedented detail. When stained with di-4-ANEPPS, the transverse tubules are readily visualized with nonconfocal imaging (Fig. 4A ). When stained with PGH1 and Rhod-2 AM, individual myocytes can be identified and subcellular recordings of APs and CaT were measured from a single pixel viewing 1.5 ϫ 1.5 m 2 and a signal-to-noise ratio Ͼ 80/1 (Fig. 4B) . Changes in CaT were analyzed by converting our two-dimensional data ( supplementary movie 1) to line scans, typically used in confocal imaging (Fig. 4D) . At BHR, the line scan (a-a=) showed CaT along the longitudinal axis of a ventricular myocyte (Fig.  4D,a) . After 5 min at a SHR, the line scans changed in two important ways: the systolic Ca i exhibited a SCR and diastolic Ca i exhibited subcellular oscillations that were not apparent at low magnification (Fig. 4D,b) . Reverting to the BHR for 5 min fully reversed these changes in subcellular Ca i (Fig. 4D,c) . These subcellular changes in Ca i handling seen at SHR were highly reproducible within the same heart and were reproduced in five hearts (Fig. 4E) . As illustrated in Fig. 5 , SCRs increased in amplitude as a function of time at SHR and were considerably more pronounced at the base than at the apex. Note the absence of SCR at a site on the apex (Fig. 5D) , whereas a well-developed SCR was present at basal site (Fig. 5C ).
The significance of SCR in bradycardia was investigated with respect to spatial and temporal synchrony among cells at the base of the heart. Figure 6 illustrates the changes in CaT in bradycardia in a two-dimensional recording as a movie (Fig.  6A , see supplementary movie 2) and as line scans along the longitudinal (Fig. 6B, top, along a-a=) and transverse (Fig. 6B , bottom, along b-b=) axis of a myocyte. The video clip shows that SCR occurs synchronously within each cell (Ͻ20 ms) and between adjacent cells although with different amplitudes in various cells. In contrast, diastolic Ca 2ϩ waves are temporally and spatially asynchronous and did not propagate across cell borders. An activation map of SCR within a cell showed that SCR was highly synchronous (Fig. 6C, top) , whereas Ca 2ϩ waves during diastole propagated slowly and were random within cells (Fig. 6C, bottom) . the amplitude of systolic SCRs and the diastolic Ca waves in a given cell was tightly correlated, suggesting a related mechanism (r ϭ 0.86 Ϯ 0.021, n ϭ 4 hearts; Fig. 6E ).
Mechanism of SCR.
To further elucidate the interplay between Ca i and voltage, experiments were carried out to assess whether SCR prolonged APD 80 or longer APD 80 elicited SCRs. In SHR, it is reasonable to expect that SCRs originate from SR Ca 2ϩ release via RyR2 because the rise of SCRs always preceded those of partial depolarizations determined from inflection time points of AP during the AP plateau (or late-phase voltage humps) by 6.4 Ϯ 1.3 ms. An agent known to stabilize RyR2, K201 (1 M, n ϭ 5) was tested for its effects on SCR. Plots of mean ⌬APD 80 as a function of time are shown during transitions from BHR to SHR from 5 ϫ 5 pixels on the LVA (Fig. 7A, top) and 5 ϫ 5 pixels on the RVB (Fig. 7A, bottom) with and without K201. The graphs show that K201 reduced mean APD 80 at pixels on the RVB (P Ͻ 0.01, n ϭ 5) but did not significantly alter AP and CaT at the apex. K201 did not alter diastolic Ca 2ϩ levels or the amplitude of CaTs. In the absence of K201 baseline drift recorded a percent change of fluorescence relative to the amplitude of CaT was Ϫ1.02 Ϯ 0.26% per min, and in the presence of K201, the slope was Ϫ1.14 Ϯ 0.16% per min (P ϭ 0.19, n ϭ 5 hearts). Similarly, the fractional change of fluorescence during a CaT, fractional fluorescence change (⌬F/F) was 0.434 Ϯ 0.11 in the absence and 0.442 Ϯ 0.126 in the presence of K201 (P ϭ 0.24, n ϭ 5).
K201 did not completely abolish APD adaptation but suppressed the difference in APD prolongation between apex and base. As shown in Fig. 7B , the suppression of SCR by K201 markedly reduced the dispersion of APD 80 and DOR at SHR (P Ͻ 0.05, n ϭ 5).
The molecular basis underlying the higher occurrence of SCR and diastolic Ca 2ϩ waves at the base compared with the apex is most likely due to heterogeneities in the expression of ion channels and transporters. As shown in Fig. 8 , the expression of the ␣-subunit of voltage-gated L-type Ca 2ϩ channel protein, Cav1.2␣; the predominant NCX protein found in the heart, NCX1, and voltage-gated Na ϩ channel, Nav1.5 proteins was significantly higher at the base (B) than the apex (A) (P Ͻ 0.05; n ϭ 7). In contrast, the levels of SERCA2A and RyR2 were not significantly different and RERG had the opposite distribution, being higher at the apex than the base (P Ͻ 0.05; n ϭ 6 hearts).
Role of SCR in bradycardia-induced ventricular ectopy. We performed a systematic evaluation of relationship between SCR and ventricular ectopy. In 5 out of 15 hearts studied at low optical magnification, bradycardia alone was sufficient to produce premature ectopic beats that were eliminated by pacing at BHR or by inhibiting SCR with K201. In the five hearts that developed ectopic beats during bradycardia, ectopic beats appeared after a few minutes (Fig. 9, B and D) and were readily abolished by reverting back to BHR (Fig. 9, C and E) . The addition of K201 had no effect on APs and CaT in BHR but blocked ectopic activity after 5 min of SHR (Fig. 9F) . The kinetics of AP and CaT upstrokes were analyzed for paced (black arrows) and ectopic beats (gray arrows; Fig. 9G ). Activation maps of the paced beats and ectopic beats show that paced beats were initiated at the location of the stimulus electrode and ectopic beats emanated from the RVB, leading to a wavefront that collided with the paced wavefront (Fig. 9H) . For all paced beats, V m preceded Ca i (not shown) but Ca i preceded V m for all ectopic beats at their origins, located at the base and most often on the RVB (Fig. 9, H and I, site a) . However, as the ectopic beat propagates away from its origin, V m preceded Ca i (site b; Fig. 9, H and I) .
DISCUSSION
HR is an important mechanism used by mammals to adjust cardiac output to changing demands. The adaptive role of tachycardia in a fight-or-flight situation is well accepted, as is the diminished myocardial energy consumption during bradycardia. Several parameters of cardiac contraction have to adjust to dynamic HR changes. At the cellular level, this requires an adaptation of APD and CaT in response to a change in HR.
This study showed that bradycardia changes in Ca 2ϩ dynamics are spatially heterogeneous, being more pronounced at the base of the ventricles. Bradycardia elicits an SCR occurring during the AP plateau, which are synchronous within a given cell and within the myocytes in the high-power field of view. It also leads to diastolic SR Ca 2ϩ release in the form of propagated Ca 2ϩ waves, which are not synchronized among adjacent cells. Ca 2ϩ imaging at low magnification demonstrated a tight correlation of SCR with enhanced APD. Interestingly, high-magnification Ca 2ϩ imaging was required for detection of diastolic Ca 2ϩ waves, since their detection was prevented by their lack of tight temporal synchronization and by spatial averaging over the multiple myocytes comprising a low-magnification pixel.
It is possible that the higher expression of Cav1.2␣ and NCX1 at the base of the heart reported here and elsewhere may partially explain the spatial heterogeneity of Ca 2ϩ handling during bradycardia, e.g., by causing a higher degree of SR load at the ventricular base.
In principle, ectopic activity induced by bradycardia could be attributed to a spontaneous reactivation of I Ca,L , independent of altered Ca 2ϩ dynamics. Alternatively, bradycardia could promote SR Ca 2ϩ overload and produce SCR that activates a depolarizing I NCX , with I NCX causing the initial depolarization, which results in I Ca,L reactivation. In our opinion, compelling evidence implicates SCR as the initial trigger of EADs and ectopic activity in bradycardia. First, SCR frequently occurred with no apparent voltage deflection, and when EADs were present, the SCR onset preceded EAD onset by 5-10 ms at the site of the ectopic focus. Second, pharmacological intervention with K201, a RyR2 stabilizer, suppressed SCR, DOR, EADs, and ectopic activity, yet had no significant effect on APD and CaT at the apex or sites that had no SCR. The effect of K201 on SCR could not be attributed to an indirect effect on Ca 2ϩ load, since K201 did not alter baseline Ca 2ϩ compared with controls. Given the stability and signal quality of Ca i measurements, K201 did not alter diastolic Ca i .
Triggered activity in bradycardia and impaired repolarization. Slow ventricular rate is an established proarrhythmic factor known to increase the propensity to TdP, an arrhythmia associated with delayed repolarization (40, 54) . Abnormal Ca 2ϩ handling and spontaneous SR Ca 2ϩ release has been suggested as the mechanism of EADs, the form of triggered activity which underlies TdP. (18, 55, 62) We have recently reported that in rabbit hearts with LQT2, TdP elicited by bradycardia and delayed rectifying K ϩ current (I Kr ) blockade exhibited Ca i oscillations during APD prolongation that preceded the appearance of EADs by minutes (38) . The data suggest that Ca i oscillations are caused by spontaneous SR Ca 2ϩ release that activates a depolarizing I NCX that serves as a trigger to EAD generation. This study was motivated by the need to elucidate the relationship between bradycardia, Ca 2ϩ handling and arrhythmogenesis. We observed that bradycardia alone caused a lesser degree of SCR, sometimes manifested as delayed CaT downstroke rather than CaT reelevation. This could facilitate the generation of EADs when repolarization is impaired and occasionally suffice to trigger EADs on its own.
Bradycardia has long been known to prolong APDs and enhance DOR, setting the stage for functional reentry, but the mechanisms that enhance APD and DOR are not well understood. Here, we report that bradycardia produces the expected gradual increase of APDs and decrease of diastolic Ca i . SCR contributes to spatial heterogeneities of APD and enhanced DOR, since its elimination reduces DOR.
Mechanism underlying SCR. The mechanism whereby bradycardia promotes SCR is uncertain at this moment. In principle, increased diastolic interval during bradycardia should allow more time for Ca i removal out of the cell by NCX. However, SR Ca 2ϩ pumps can effectively compete with NCX Protein density was normalized with respect to ␤-actin to compare levels of channel proteins between RVA and LVA. A: relative density of RVB vs. LVA densities for voltage-gated L-type Ca 2ϩ channel (Cav1.2␣), Na ϩ -Ca 2ϩ exchange (NCX1; dominant isoform of NCX in heart), sarcoplasmic reticulum Ca 2ϩ ATPase 2a (SERCA2A), ryanodine receptor 2 (RyR2), and rabbit ether-a-go-go-related gene (RERG). B: summary of density histograms shows statistically significant 2-fold upregulation of Cav1.2␣, NCX1, and voltagegated Na ϩ channel (Nav1.5) at RVB compared with LVA (P Ͻ 0.05, n ϭ 7 hearts). There were no significant differences between RVB and LVA for SERCA2A, RyR2, and RERG (P Ͼ 0.05, n ϭ 7 hearts). for the removal of Ca i during bradycardia. The amount of Ca i transported to the lumen of the SR by SERCA during each cardiac cycle may actually be higher during bradycardia due to 1) longer AP plateau (perhaps a contribution of reduced I Kr at the base), 2) longer duration of Ca 2ϩ influx through L-type channels, and 3) the reduced NCX driving force during more positive plateau potentials. If there is a significant diffusion limitation of Ca 2ϩ movement between the uptake and release compartments of the SR, the junctional SR may be replenished after the initial phase of Ca 2ϩ -induced Ca 2ϩ -release from the nonjunctional compartment during each heartbeat to a degree which allows spontaneous Ca 2ϩ release through RyR2 in at least some myocytes. This process should be augmented by any intervention which prolongs plateau duration, such as I Kr blockade.
Ca i imaging shows that SCR occurs uniformly within each cell and is temporally synchronous among neighboring cells despite cell-to-cell differences in ASCR. The temporal synchronization can be attributed to similar time needed to overload the lumen of the SR network during long APDs due to incomplete voltage-dependent inactivation of L-type Ca 2ϩ channels.
It is likely that SR loading is accentuated in regions with increased I Ca,L density. This is consistent with the observation of SCR occurring preferentially at basal regions of ventricular myocardium. We previously reported that female rabbit hearts express higher protein levels of Cav1.2␣ and NCX1 and have significantly higher current densities of I Ca,L and I NCX (25-30%) at the base compared with the apex. The greater Ca 2ϩ influx via I Ca,L and reverse mode I NCX lead to greater SR Ca 2ϩ overload and a greater propensity to EADs in female myocytes isolated from the base compared with those isolated from the apex, endocardium or isolated from male hearts (17, 52, 65) .
SCR prolong APD. While AP prolongation caused by bradycardia may be the primary cause for SCR development, it appears likely that once SCRs occur, they may themselves prolong APD. We suppressed SCR with K201 to confirm their causative effect on APD prolongation. K201 has been found to stabilize the closed state of cardiac RyR (26, 33) and suppress the nonvoltage-triggered Ca 2ϩ leak caused by RyR2 mutations or phosphorylation. K201 eliminated SCR and attenuated AP prolongation and DOR during bradycardia. Admittedly, K201 may have off-target effects which must be carefully considered. In guinea pig ventricular myocytes, K201 (1 M) inhibited I Na , I Ca,L , and I Kr in addition to its effect on RyR2 (30, 31) ; however, these off-target effect appear to be species dependent. In rabbit myocytes, K201 was specific for RyR2 at 1 M: it imaging at the subcellular level, with most studies performed on isolated myocytes (8, 10, 46) , Purkinje fibers (19, 28, 53) , superfused myocardial trabeculae (34, 35, 37, 48) , and myocyte monolayers (7, 36) . Although intact perfused hearts provide significant advantages compared with isolated preparations to study arrhythmias, technical difficulties (e.g., greater susceptibility to motion artifact, scan rate, and signal-to-noise ratio) have made subcellular Ca 2ϩ imaging challenging in this setting. At least three groups have now used confocal microscopy to study abnormalities of Ca 2ϩ in various models of cardiac arrhythmias, such as ventricular hypertrophy, hypokalemia, rapid pacing, and delayed afterdepolarization after cessation of rapid pacing (1, 2, 6, 23) . A common finding was that nonvoltage-triggered diastolic Ca 2ϩ release often produced subcellular Ca 2ϩ waves that appeared to play a crucial role in the genesis of arrhythmias. However, the role of abnormal Ca 2ϩ dynamics will be difficult to analyze in other situations, such as ischemia, repolarization delay, or bradycardia, where longer intervals of data acquisition are needed at both high and low spatial resolution. Whereas confocal imaging in the linescan mode reaches the necessary high sampling frequency, the field of view is relatively small and cannot be switched from line-scan to macroscopic imaging to track an arrhythmia throughout the intact heart. In addition, most confocal experiments were performed at room temperature because the fluo4 fluorescence diminishes above 30°C but hypothermia can have profound effects on Ca 2ϩ dynamics. The method we used here overcomes some of these technical problems.
Study limitations. This investigation studied the effects of acute bradycardia and may be less clinically relevant than animal models of chronic bradycardia where considerable tissue remodeling occurs (20, 58, 59) . The study focused on the epicardium and did not investigate SCR from different regions of the ventricles. Although our previous studies demonstrated higher levels of I Ca,L and I NCX occurred at the base of the rabbit epicardium and not on the endocardium (17, 52), we cannot exclude the possibility of SCR in other regions of the heart. In pilot studies, optical maps of APs and CaT at high and low magnification from the endocardium did not find SCR before and during bradycardia. Unfortunately, optical recordings are still limited to the surface.
The study suggests that bradycardia causes an extra APD prolongation at the base by eliciting SCR and I NCX augmentation. Several pharmacological agents can be used to suppress SCR by RyR2 inhibition. We used K201 because of its selectivity in rabbit hearts and because alternative agents flecainide and ranolazine also suppress SCR but have significant effects on the I Na,L and I Ca,L . Pilot studies tested pharmacological blockers of NCX to evaluate more directly its impact on APD prolongation during bradycardia. Unfortunately, the available NCX inhibitors are not sufficiently selective or effective at blocking NCX. Trials with SEA0400 (0.1-2 M) to block the forward mode of NCX were inconclusive because at these concentrations, inhibition of NCX is partial, and at concentrations Ͼ 1 M, I Ca,L is progressively suppressed (11) . An alternative approach of lowering external Na ϩ has been successfully used to inhibit I NCX in isolated myocytes but cannot be applied fast enough in perfused hearts. Likewise, caffeine can be effectively used to estimate SR Ca 2ϩ load in isolated myocytes but not in perfused hearts. Nevertheless, these limitations do not detract from the validity of the study which exemplifies what can be done at the intact heart level to fully appreciate heterogeneities and complexities that cannot be exposed in studies with isolated myocytes.
In summary, the study investigates acute abnormalities of myocardial Ca 2ϩ handling caused by bradycardia, which increases propensity to ectopic activity and promotes arrhythmia. A recent elegant study has shown the role of remodeling of Ca 2ϩ handling processes for arrhythmia in chronic bradycardia (58) . At the subcellular level, the mechanisms of SCR clearly merit additional investigation. Clinically, it is possible that RyR2 stabilizers and NCX blockers could have a role in acute treatment of bradycardia-induced TdP, at least until pacing therapy can be instituted.
